SOUTH SAN FRANCISCO, CA and VANCOUVER, BC –– ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer,… Read More
Recommendations Published online in Annals of the Rheumatic Diseases Propose That Physicians Consider Earlier Intervention with Therapies Including LUPKYNIS® (voclosporin) as a New LN Treatment Paradigm ROCKVILLE, Md. & EDMONTON, AB — Aurinia… Read More
Data highlights progress in developing bioprinted tissue therapeutics to treat acquired and congenital liver diseases VANCOUVER, BC — Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics,… Read More
As a result of the largest gift in Canadian history for liver cancer, BC Cancer is establishing a unique multi-disciplinary liver cancer program, led by Dr. Pamela Hoodless (Director & Distinguished… Read More
WELL’s Cybersecurity Business Unit, Cycura, has acquired Seekintoo, a provider of Cybersecurity Operations Center services, ensuring enterprise clients receive 24/7 vigilant threat protection through managed detection. Cycura has also acquired… Read More
